How to Actually Judge a Cancer Hospital — the Five Things That Matter

---

Most lists of the best cancer hospitals in India rank hospitals by reputation or by how famous the name is. That is a poor way to choose where to have your cancer treated.

Reputation tells you what a hospital was good at ten years ago. It does not tell you whether the specific surgeon who will operate on you next month does fifty of your operation a year, or three hundred. That difference matters enormously, and it is invisible on a glossy ranking.

Here are the five things that genuinely separate a good cancer outcome from a poor one. Judge every hospital on your shortlist against all five.

1. Volume — how many of your exact case the team does each year

This is the single strongest predictor of outcome in cancer surgery, and it is one of the most replicated findings in the medical literature. A surgeon who performs 200 of a particular operation a year gets cleaner margins, fewer complications, and better recovery than one who performs 40.

This is also where India's top programmes quietly outperform what many Western patients find at home. A patient at a regional hospital abroad may be operated on by a surgeon doing 40 to 80 cases a year. At Tata Memorial, Fortis FMRI or Medanta, the specialist may be doing several hundred. Ask the number. A good hospital will tell you.

2. The multidisciplinary tumour board

Modern cancer care is never one doctor's decision. The best centres run a tumour board — a meeting where surgical, medical and radiation oncologists, radiologists and pathologists sit together and agree your plan as a team.

If a hospital cannot tell you that your case will go through a tumour board, treat that as a warning sign. A single surgeon recommending surgery, or a single radiation doctor recommending radiation, is not the same as a balanced team weighing every option for you.

3. Accreditation

Accreditation is your proof that the hospital meets recognised standards for safety, hygiene, and quality — independently checked, not self-declared. We cover exactly what each accreditation means in the next section, because for an international patient it is one of the easiest things to verify and one of the most important.

4. Technology that matches your cancer

Technology only matters if it is relevant to your diagnosis. Proton therapy and CyberKnife are remarkable for certain tumours and irrelevant for others. A Da Vinci robot matters for prostate and some abdominal cancers and not at all for a blood cancer.

Do not be impressed by a long list of machines. Ask the narrower question: what is the best available treatment for my exact cancer, and does this hospital have it?

5. International patient infrastructure

For someone travelling from abroad, this is not a luxury. A dedicated international patient desk, visa-letter support, interpreters, and a clear follow-up plan for after you fly home are the difference between a smooth treatment and a stressful one.

Accreditation Explained — JCI, NABH, NABL and AACI in Plain Language

---

When you read that a hospital is "JCI and NABH accredited," it is easy to skim past the letters. For an international patient choosing a cancer hospital, those letters are one of the few quality signals you can verify yourself, from your own country, before you go anywhere.

Here is what each one actually means.

JCI — the global gold standard

Joint Commission International is the same body that accredits leading hospitals in the United States and across the world. When an Indian hospital holds JCI accreditation, it has been independently assessed against international patient-safety standards — the same benchmark a top American hospital is held to.

India has more than fifty JCI-accredited hospitals. For an international patient, JCI is the single most reassuring accreditation to look for, because it removes the guesswork about whether "Indian standards" match what you are used to at home. They do.

NABH — India's national standard

The National Accreditation Board for Hospitals is India's own accreditation system, broadly equivalent in rigour to national hospital accreditation in other countries. Almost every serious cancer hospital in India holds NABH. Its absence is a far bigger warning than its presence is a reassurance.

NABL — for the laboratory and diagnostics

Cancer treatment lives and dies on accurate diagnosis. NABL accredits the testing laboratories — the pathology and the molecular diagnostics that determine your exact cancer type and the right drugs for it. A wrong lab result leads to a wrong treatment, so NABL matters more in oncology than in almost any other field.

AACI — the dedicated cancer-network standard

A smaller number of centres hold accreditation specific to cancer care. HCG, for example, is recognised as India's AACI-accredited dedicated cancer network. For a patient whose only concern is oncology, a cancer-specific accreditation is a meaningful extra layer of assurance.

The Leading Cancer Hospitals in India — Who Leads in What

---

Below are the centres that international patients ask about most often, grouped by what each is genuinely strong at. This is not a ranking. A centre placed lower here may be the best possible choice for your particular cancer.

Tata Memorial Hospital, Mumbai

Founded in 1941, Tata Memorial is India's oldest and most respected cancer institution, and it led the evidence-based medicine movement in Indian oncology. It treats an enormous patient volume across nearly every cancer type, and much of India's cancer research and protocol-setting happens here.

For an international patient, Tata offers world-class expertise at low cost, but it is a high-volume public institution — waiting times and crowding are real, and the experience is less concierge than a private hospital. It is often the right choice for complex or rare cancers where research-grade expertise matters more than comfort.

Apollo Cancer Centres

Apollo runs the widest private cancer network in India, holds JCI accreditation, and was the first to bring proton therapy to the country. Apollo alone receives more than 20,000 international patients a year from over 120 countries, with the international-patient machinery to match.

For an overseas patient who values smooth logistics, broad technology access and a single network across several cities, Apollo is frequently the most practical choice.

Fortis Memorial Research Institute (FMRI), Gurugram

FMRI is a JCI and NABH-accredited quaternary centre with one of India's largest bone marrow transplant programmes, advanced robotics including the Da Vinci system, and a dedicated international patient division that receives referrals from more than thirty countries.

It is repeatedly cited for high surgical volumes in complex oncology, which — as we have said — is exactly what should reassure you.

Medanta — The Medicity, Gurugram

Medanta offers multidisciplinary cancer care with internationally trained specialists and full support from other specialties on the same campus — which matters when a cancer patient also needs heart, liver or kidney care during treatment. It is widely cited for surgical oncology and for thoracic cancers.

RGCIRC, Delhi and HCG Oncology

Rajiv Gandhi Cancer Institute in Delhi is a NABH, NABL and JCI-recognised non-profit dedicated cancer centre treating around 60,000 patients a year, and it was named among the world's best specialised oncology hospitals by Newsweek and Statista. HCG runs India's only AACI-accredited dedicated cancer network, with strong radiation and hemato-oncology programmes across several cities.

Both are strong options for patients who specifically want a dedicated cancer institution rather than an oncology department inside a general hospital. To see how these centres line up for one specific cancer, the best hospitals for prostate cancer in India guide compares them head to head.

Side-by-Side Comparison of India's Top Oncology Centres

---

No single hospital wins on every row. Read this the way you would read it for your own case — find the rows that matter most for your cancer and your situation, and weigh those.

Factor	Tata Memorial	Apollo	Fortis FMRI / Medanta
Type	Public / research	Private network	Private quaternary
Accreditation	WHO / ICMR recognised	JCI + NABH	JCI + NABH
Best known for	Complex / rare cancers, research	Proton therapy, wide network	High-volume surgery, BMT, robotics
International patient desk	Limited	Extensive (120+ countries)	Dedicated (30+ countries)
Waiting time	Can be long (high volume)	Short	Short
Patient experience	Busy, less private	Concierge-level	Concierge-level
Relative cost	Lowest	Moderate–high	Moderate–high
Best fit for	Rare cancers, tight budgets	Smooth logistics, proton cases	Surgery, transplants, robotics

Public vs Private — Which Is Right for an International Patient

---

This is the trade-off that confuses most overseas patients, and the honest answer is that it depends on what you are optimising for.

Public institutions like Tata Memorial and AIIMS offer extraordinary expertise at heavily subsidised cost. For a rare or complex cancer, the research-grade depth at these centres can be unmatched anywhere in the region. The trade-off is crowding, longer waits, and a far less comfortable experience — which is harder when you are far from home and unwell.

Private hospitals like Apollo, Fortis, Medanta and Max offer quicker access, private rooms, full international-patient support, and the same advanced technology — at a higher, though still globally affordable, price. For most international patients, the smoother logistics and shorter waiting times of a private centre are worth the difference.

There is no shame in choosing comfort and speed when you are sick and travelling. There is also no shame in choosing a public research centre for a rare cancer where expertise outranks everything. What matters is that the choice is deliberate and matched to your diagnosis.

What Cancer Treatment in India Actually Costs — Full Breakdown

---

Cancer treatment in India typically costs 60 to 80 percent less than the equivalent treatment in the United States or United Kingdom. This is the single biggest reason international patients come.

It is worth being clear about why. It is not because the equipment is older or the surgeons less trained. The Da Vinci robot in Gurugram is the same machine as the one in Houston, and many Indian oncologists trained in the West. The difference is structural — labour, infrastructure and administrative costs in Indian healthcare are simply far lower than in Western systems.

The numbers below are broad ranges for the treatment itself at a good private hospital. Your real figure depends on your cancer, your stage, and exactly what your plan involves — which is why a written estimate for your specific case matters more than any range.

Treatment	India (JCI hospital)	USA (private)	UK (private)
Chemotherapy (per cycle)	USD 400–1,500	USD 3,000–7,000	GBP 2,000–5,000
Radiation therapy (full course)	USD 3,000–7,000	USD 15,000–50,000	GBP 10,000–30,000
Robotic cancer surgery	USD 6,000–12,000	USD 30,000–60,000	GBP 15,000–30,000
Bone marrow transplant	USD 18,000–35,000	USD 100,000–300,000	GBP 80,000–200,000
Proton therapy (full course)	USD 20,000–35,000	USD 80,000–150,000	GBP 60,000–120,000
PET-CT staging scan	USD 400–800	USD 3,000–6,000	GBP 2,000–4,000

Remember that the treatment bill is not the whole picture. For an international patient, the real number includes accommodation for the duration of treatment, food, local travel, and return flights. Even with all of that added, the saving against the United States or United Kingdom usually remains very large.

Accommodation near the major hospital clusters in Gurugram, Delhi, Mumbai and Chennai runs roughly USD 30 to 80 a night for a serviced apartment suitable for a patient and a companion. For a fuller picture of one cancer's total cost, the prostate cancer treatment cost in India breakdown shows how the pieces add up trip by trip.

Planning Your Treatment Trip — a Practical Guide

---

Travelling to India for cancer treatment feels overwhelming before you start and far simpler once it is organised. The trick is to settle the important things before you fly, so your time in India is spent on treatment and recovery, not on logistics.

What to send before you travel

Gather your full pathology or biopsy report, any scans you have had such as CT, MRI or PET-CT, your recent blood results, and a short written summary of your diagnosis and any treatment so far. Most major Indian hospitals review electronic copies for a pre-consultation, so you can get a clear plan and an estimate before you book a single flight.

Medical visa

You need an Indian e-Medical Visa, not a tourist visa. The application requires an invitation letter from the treating hospital, which GAF Healthcare provides as standard. Processing usually takes three to five working days for most nationalities, and a medical visa allows multiple entries to cover your full treatment.

The pre-treatment video consultation

Never travel without speaking to your proposed oncologist first. A video consultation lets the specialist review your imaging directly, explain exactly what your treatment will involve, and answer every question — so you decide to travel with full information, not on hope. This single conversation prevents most of the disappointment patients fear about treatment abroad.

After treatment — before you fly home

Before you leave, confirm your follow-up plan in writing. Know when your next scan or blood test is due, what results should prompt urgent contact, and who to reach. A good hospital gives you a discharge pack with your full treatment summary, your drug list, and your specialist's direct contact details for your doctor at home.

Continuity of care is the part patients underestimate most. The best international cancer programmes stay reachable for video follow-up and urgent questions after you return home — you should not feel cut off the moment you land back in your own country.